Amrita Hospital's Nuclear Medicine Department celebrates Silver Jubilee

Kochi: The Nuclear Medicine Department at Amrita Hospital is celebrating its silver jubilee. As part of the celebration a two-days' long unique live conference titled Amrita Sentinel 2025 is being conducted.

Dr Prem Nair, Medical Director of the Amrita Hospitals Group, was the chief guest at the inaugural event. Dr. Brigadier Ajoy Menon, Senior Medical Administrator of Amrita Hospital, Dr. Prathapan Nair, Medical Administrator, Dr. Shanmuga Sundaram, Head of the Department of Nuclear Medicine, and Dr. Padma Subramanyam, Clinical Professor, Nuclear Medicine department at Amrita Hospital also addressed the gathering.

The event is jointly organised by the departments of Head and Neck Surgery, Breast and Gynecologic Oncology, and Endocrine Surgery at Amrita Hospital.

Also Read:Amrita Hospital Launches Third Phase of 'Dengue All' Vaccine Trial

The conference will focus on the scientific principles and modern medical significance and relevance of sentinel lymph node imaging and biopsy in early cancers of breast, Head & Neck and genecology. Experts will conduct sessions on various related topics.

Medical Dialogues had earlier reported that Dr Prem Nair, the Medical Director of Amrita Hospitals Group, has been elected as the National President of the Telemedicine Society of India. The announcement was made during Telemedicon 2024, the annual international conference of the society, held at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh.

Currently, Dr Prem Nair serves as the founding President of the Kerala chapter of the Telemedicine Society of India, a release said.

Dr Prem Kumar Vasudevan Nair currently serves as the Medical Director at Amrita Institute of Medical Sciences at the Kochi campus of Amrita University. He is a skilled clinician par excellence and also serves as a Professor at the Department of Gastroenterology at the School of Medicine, Kochi.

Also Read:Amrita Hospital Faridabad unveils Centre of Excellence for CAR T-Cell Therapy